• No image available for this medication

    • ASTHMANEFRIN REFILL

    • QTY 1
    • 2.25 %
    • VIAL-NEB

RACEPINEPHRINE (RACE ep i NEF rin) treats lung diseases, such as asthma, where the airways in the lungs narrow, causing breathing problems or wheezing (bronchospasm). It works by opening the airways of the lungs, making it easier to breathe. It is often called a rescue or quick-relief medication.

ASTHMANEFRIN REFILL Lifestyle Interactions

  • Racepinephrine Hydrochloride 2.25%, Nebulizer solution

    • Interaction: Caffeine-containing Foods/Beverages
    • Severity: Moderate
    • Notes for Consumers: Limit excessive Caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while using Racepinephrine inhalation and avoid medicines containing additional Caffeine whenever possible. This includes a herbal weight loss products or dietary supplements which claim to have a stimulant or "stay awake" effect. Taking a high amount of Caffeine with Racepinephrine inhalation can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, or other side effects.
    • Notes for Professionals: Patients who are using racepinephrine inhalation are advised to avoid foods and beverages that contain caffeine. They should also avoid dietary supplements containing ingredients, such as caffeine, that are reported or claimed to have a stimulant effect. If a patient is taking prescribed medications containing caffeine, then they should seek health care professional advice prior to the use of racepinephrine. Additive adverse effects on the cardiovascular and nervous system are possible, some which may be undesirable. Side effects such as nausea, tremor, nervousness, difficulty with sleep, and increased heart rate may be additive. Consider alternatives to racepinephrine for the treatment of asthma.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.